CD19 and head and neck squamous cell carcinoma: We first quantified frequencies of TIL-Bs and plasma cells in HNSCC primary tumors (Supplementary Table 2, Cohort 2), which revealed a significant increase in CD19+CD20+ TIL-Bs compared to plasma cells in the TME (Supplementary Fig. 6a,b).